Lantern was granted these rare pediatric disease designations in: malignant rhabdoid tumors (MRT), rhabdomyosarcoma (RMS), and hepatoblastoma. Lantern's investigational drug candidate, LP-184, has ...

Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Throughout the McFarland’s ordeal, the Children’s Cancer Network became the family’s ally.

THEY TOLD ME THAT THEY FOUND A LESIONS ON HER LIVER. THEY THEN WENT TO MUSK IN CHARLESTON, WHERE THEY DIAGNOSED KYLIE WITH ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

The laboratory is discovering new ways to target therapy for pediatric solid tumors, with a focus on neuroblastoma, hepatocellular carcinoma, and hepatoblastoma. Although rare, pediatric liver cancers ...

Pink Arrow game, hosted by the Lowell Red Arrows, is not just another high school football match. It’s a night when the ...

A young boy has enjoyed his first day at school after being diagnosed with cancer when he was just two years old ...

An Upstate mom shares the uphill battle to recovery from her daughter's cancer and is grateful for where they are now. Kylie Jeter, 3, is an energetic little girl, but just a few years ago, it was a ...

Typically, ultrasonography is the first-line imaging method of evaluating children with liver tumors. But few studies were performed to describe in detail the differentiation between the two types ...